N

Noah Medical

Medical robotics system for lung diagnostics

Senior Human Resources Manager - HR

Full-TimeUpdated on 10/23/2026
$170k - $210k+ Equity + Bonus
Senior, Expert
Bachelor's
San Jose, CA, USA
In PersonWork arrangements may be remote, hybrid, or onsite within California depending on the team or role.
People & HRHR Operations & Coordination, HR Generalist & Employee Relations

About the job

Requirements
  • At least 8 years of progressive Human Resources experience, including hands-on experience in HR business partnership and HR operations; applicants with a strong HR operations background receive priority consideration.
  • Experience partnering directly with business leaders and managers on day-to-day people matters, performance management, employee development, and organizational needs.
  • Experience managing sensitive employee matters, performance issues, corrective actions, and workplace investigations.
  • Experience with employee lifecycle processes, onboarding and offboarding, employee changes, HR documentation, and employee data management.
  • Experience supporting and executing performance-management and review cycles and coaching managers through performance conversations.
  • Working knowledge of California and federal employment requirements and HR best practices.
  • Experience maintaining accurate and timely HRIS data and processes; experience with Rippling or a similar HRIS is preferred.
  • Strong communication, judgment, discretion, problem-solving, and organizational skills, with attention to detail.
  • Ability to build trusted relationships across the organization while remaining hands-on, responsive, and execution-focused.
  • Ability to work in a fast-paced, growing environment and balance strategic People initiatives with day-to-day operational needs.
  • Bachelor’s degree in Human Resources, Business, or a related field, or equivalent relevant experience.
Responsibilities
  • Own and execute day-to-day HR operations, ensuring People processes are completed accurately, consistently, and in a timely manner.
  • Maintain accurate and timely employee data in Rippling, including employee changes, documentation, approvals, and ongoing data integrity.
  • Coordinate onboarding and offboarding with internal stakeholders and ensure a consistent employee experience and effective handoffs across teams.
  • Manage employee lifecycle changes, including internal transfers, promotions, manager changes, organizational updates, and other employment changes.
  • Maintain HR documentation, policies, processes, and employee records while supporting compliance with applicable employment requirements.
  • Identify opportunities to improve and streamline HR processes, systems, and workflows as the organization grows.
  • Execute and support company-wide People programs and initiatives, including performance reviews, employee development, engagement, organizational planning, and manager development.
  • Partner with People leadership to translate People strategies and programs into effective processes, communications, and day-to-day execution.
  • Use people data and trends, including headcount, turnover, employee changes, and employee feedback, to identify opportunities and provide insights to People leadership and business leaders.
  • Support organizational changes and People-related projects from planning through implementation, ensuring coordination, communication, and follow-through.
  • Manage employee relations matters, including workplace concerns, performance issues, corrective actions, and employee investigations, partnering with People leadership and Legal as appropriate.
  • Provide practical guidance to managers and employees on company policies, HR practices, and workplace matters.
  • Partner with People leadership to execute performance-management and review cycles, including goal setting, manager guidance, feedback, performance conversations, development planning, and follow-through.
  • Support employee engagement and development initiatives and help managers translate employee feedback into actions.
  • Serve as a trusted HR partner to business leaders and managers, providing day-to-day guidance on people, performance, and organizational matters.
  • Build relationships with leaders and employees to understand business needs and translate People priorities into practical solutions.
  • Coach and advise managers on performance management, employee development, team effectiveness, organizational needs, and people-management practices.
  • Partner with leaders on workforce needs, organizational changes, internal transitions, role clarity, and evolving business needs.
  • Partner with Talent Acquisition on workforce planning, hiring priorities, employee transitions, and the integration of new hires.
  • Partner with Compensation & Benefits on performance and review cycles, employee changes, compensation-related processes, leaves, and other employee programs.
  • Collaborate with Finance, Legal, IT, Administration, and other cross-functional partners to execute People processes and organizational initiatives.
  • Support broader People Team priorities and special projects based on evolving business needs.
Desired Qualifications
  • Experience with Rippling or a similar HRIS.
  • Experience in medical device, healthcare, life sciences, technology, or another regulated industry.

About the company

NoahMed develops medical robotics systems for pulmonology, focusing on early diagnosis. Its flagship Galaxy System with TiLT+ Technology mitigates CT-to-body divergence to improve diagnostic yield and provides real-time navigation updates in all lung areas. It features an augmented fluoro overlay that guides locating non-visual lesions and a single-use bronchoscope with accessories to reduce cross-contamination and speed turnover, all in a compact, single-cart design for crowded operating rooms. The company differentiates itself through TiLT+ navigation, real-time augmented guidance, and a disposable—rather than reprocessed—bronchoscope setup, aiming to improve diagnostic confidence and efficiency. Its goal is to enhance early lung diagnosis with more reliable guidance, reducing procedure time and improving outcomes for patients in collaboration with interventional pulmonologists.

Company Size

201-500

Company Stage

Series B

Total Funding

$150M

Headquarters

Redwood City, California

Founded

2018

Get referred to Noah Medical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Noah launched Galaxy II on August 11, 2026, deepening installed-base monetization.
  • Prince of Wales Hospital completed Noah's first commercial Asia procedure on September 29, 2026.
  • The company reports 16,000-plus U.S. procedures and 50-plus systems, supporting adoption.

What critics are saying

  • FDA Class II recalls in 2024 and 2025 expose quality-system weakness at Galaxy.
  • Hong Kong IPO plans depend on China expansion, where approvals and execution can slip.
  • Intuitive, J&J, Medtronic, and Olympus can outspend Noah and squeeze pricing.

What makes Noah Medical unique

  • Galaxy II combines HD-DT and CBCT in one bronchoscopy platform, launched August 2026.
  • Single-use bronchoscope accessories reduce reprocessing burden and cross-contamination risk for hospitals.
  • Prince of Wales Hospital and University of Chicago validate Noah's early lung-nodule workflow.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Mental Health Support
  • Legal Services
  • Pet Insurance
  • 12+ Paid Holidays
  • 15-20 Days of PTO
  • Paid Parental Leave
  • In-office Snacks and Beverages

Growth & Insights and Company News

6 month growth

2%

1 year growth

0%

2 year growth

3%
Tech in Asia
Aug 28th, 2026
SoftBank-backed Noah Medical plans $100m Hong Kong IPO.

SoftBank-backed Noah Medical plans $100m Hong Kong IPO. SoftBank-backed Noah Medical, a US-headquartered medical robotics company, is preparing for a Hong Kong initial public offering that could raise more than US$100 million, founder Zhang Jian said. The company could file for the listing as early as next year, Zhang said the company chose Hong Kong to support its expansion in mainland China after winning approval from China's drug regulator in November last year. Noah plans to sell more surgical robots in top-tier and emerging mainland cities, including Hangzhou. It is targeting Sir Run Run Shaw Hospital there. Zhang added that Hong Kong's Prince of Wales Hospital bought Noah's equipment. Noah's flagship Galaxy System, used for robotic navigated bronchoscopy, received US Food and Drug Administration clearance in 2023. About 90% of Noah's revenue comes from the US, where its surgical robots have been used to treat about 15,000 patients, according to Zhang. Before the planned initial public offering, Noah raised US$150 million in a 2023 series B round. Stay updated on the go with our mobile app. Get latest insights with smoother, more personalized experience through TIA mobile app. How would you feel if you could no longer use Tech in Asia? Share, tag us, and land on our Wall of!

Surgical Robotics Technology
Aug 11th, 2026
Noah Medical announces galaxy(tm) II.

Noah Medical announces galaxy(tm) II. 11th, August 2026 2 mins read Noah Medical has announced the commercial launch of the Galaxy II software, the next evolution of the company's robotic-assisted bronchoscopy (RAB) platform. The Galaxy II software gives physicians imaging flexibility and procedural control to take on their most complex cases with confidence, advancing what bronchoscopy can deliver across every dimension of the procedure. Lung cancer remains the leading cause of cancer death worldwide, and survival depends heavily on early diagnosis, making the ability to accurately biopsy small, hard-to-reach lung lesions one of the most consequential steps in a patient's path to treatment. At the center of the system is Dual-Mode Imaging, which lets physicians move seamlessly between Galaxy's High- Definition Digital Tomosynthesis (HD-DT) and Cone-Beam CT (CBCT) at any point in a procedure. HD-DT delivers efficiently and effectively across the vast majority of cases at a fraction of the radiation dose, while CBCT is available at the moment a case calls for more. The result puts the imaging decision where it belongs, in the physician's hands. "Galaxy II software puts physicians in control of their imaging strategy for every procedure," said Jian Zhang, founder and CEO of Noah Medical. "By bringing HD-DT, CBCT, and advanced robotic control together in one platform using the Galaxy II software, we let physicians choose what each case requires, enabling them to adapt to each patient's anatomy and reduce radiation exposure while maximizing procedural efficiency." Accurately reaching and sampling small pulmonary lesions remains difficult due to two persistent challenges: CT-to-Body Divergence, where the preoperative CT no longer matches the patient's anatomy during the procedure, and Tool-Tissue Divergence, where a biopsy tool drifts from its intended path even when the catheter is well positioned. Galaxy II software addresses both by uniting navigation, imaging, and real-time confirmation of the lesion and tool in a single platform. "The Galaxy System's unique ability to correct for tool-tissue divergence in real time drives its high diagnostic yield, giving physicians confidence that their biopsy tool is exactly where they intend it," said Dr. Francisco Almeida, Interventional Pulmonologist at City of Hope(R) Cancer Center Atlanta. "Galaxy II software builds on that foundation, enhancing navigation, imaging, and confirmation in a single platform. It puts the choice of imaging modality in the physician's hands, so procedures run more efficiently while also cutting the radiation burden on patients and clinicians."

Associated Press
Aug 11th, 2026
Noah Medical launches Galaxy II software with dual-mode imaging for robotic bronchoscopy

Noah Medical has launched Galaxy II software for its robotic-assisted bronchoscopy platform. The system features Dual-Mode Imaging, allowing physicians to switch between High-Definition Digital Tomosynthesis and Cone-Beam CT during procedures. The technology addresses challenges in biopsying small lung lesions by combining navigation, imaging, and real-time confirmation in one platform. HD-DT provides imaging at up to 10 times lower radiation dose than CBCT for most cases, whilst CBCT remains available for complex procedures. The Galaxy System demonstrated 96.7% diagnostic yield in the multicentre MATCH II study and 90% yield in routine clinical practice at Cleveland Clinic across 100 consecutive patients. Lung cancer remains the leading cause of cancer death worldwide, with survival heavily dependent on early diagnosis.

PR Newswire
Aug 6th, 2024
Memorialcare Cancer Institute At Saddleback Medical Center Offers Next Generation Robotic Bronchoscopy For Early Diagnosis And Treatment Of Lung Cancer

MemorialCare Cancer Institute uses first-of-its-kind robotic navigated bronchoscopy for greater precision and accuracy.LAGUNA HILLS, Calif., Aug. 6, 2024 /PRNewswire/ -- MemorialCare Cancer Institute's Lung Cancer Program at Saddleback Medical Center is one of just four hospitals in California equipped with the recently FDA-cleared robotic navigated bronchoscopy system. This new device from NoahMed, Galaxy System, uses integrated tomosynthesis (3D mammography) to navigate to and locate lung nodules, which are small masses in the lungs often tested for cancer.This improved visualization, along with a disposable bronchoscope, enhances precision and accuracy beyond the capabilities of existing technologies. It gives physicians access to often hard-to-reach lesions in the outer third of the lung which are often hard to biopsy. The Galaxy System can biopsy nodules smaller than 2cm, while receiving real-time lesion location updates."Lung cancer is an insidious disease causing far too high a toll on our communities," said Jayne Stewart, executive director, MemorialCare Cancer Institute, MemorialCare Saddleback Medical Center. "The Galaxy System gives physicians trained on the device a clear, direct path to improving patient diagnosis and, in turn, treatment –allowing us to catch lung cancer before it reaches less treatable, advanced stages

Yahoo Finance
May 30th, 2024
Noah Medical And Ceo Dr. Jian Zhang Named Finalists In Surgical Robotics Technology (Srt) Industry Awards

Noah MedicalNext-generation robotics company and its CEO recognized separately for pioneering work, innovative new technology, and rapid progressSAN CARLOS, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical announced today that it has been named a finalist in the prestigious Surgical Robotics Industry Awards 2024 alongside its founder and CEO Dr. Jian Zhang. This joint recognition highlights Noah Medical’s groundbreaking work in endoluminal robotics and Dr. Zhang’s visionary leadership within the industry.Noah Medical is a finalist in the Innovative Start-up category, which honors companies under six years old that have demonstrated significant potential and introduced innovative solutions to enhance surgical procedures and patient outcomes. Dr. Zhang is a finalist in the Industry Leadership category, awarded to those who have demonstrated outstanding business or commercial success, highly effective management, and a track record as a thought leader.Since the beginning of 2023, Noah Medical has announced $150 million in Series B funding , secured FDA clearance for The Galaxy System™, its fully image-integrated solution for robotic navigated bronchoscopy, and launched the platform to commercial and industry acclaim.The company’s proprietary technology is transforming the early identification and diagnosis of lung cancer by making it possible for physicians to overcome traditional imaging and navigation limitations to confidently reach nodules in the outer periphery of the lung